Rituximab for the Antiphospholipid Antibody SyndromeRituximab for the Antiphospholipid Antibody Syndrome

Dr. Kevin Deane comments on a pilot study of rituximab for the treatment of antiphospholipid syndrome. Medscape Rheumatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Viewpoint Source Type: news